Dutch multinational conglomerate
POPULARITY
Categories
462 episodes with Philips
140 episodes with Philips
122 episodes with Philips
134 episodes with Philips
59 episodes with Philips
48 episodes with Philips
44 episodes with Philips
43 episodes with Philips
35 episodes with Philips
34 episodes with Philips
177 episodes with Philips
25 episodes with Philips
23 episodes with Philips
30 episodes with Philips
12 episodes with Philips
18 episodes with Philips
16 episodes with Philips
21 episodes with Philips
21 episodes with Philips
12 episodes with Philips
28 episodes with Philips
28 episodes with Philips
20 episodes with Philips
13 episodes with Philips
10 episodes with Philips
27 episodes with Philips
10 episodes with Philips
7 episodes with Philips
14 episodes with Philips
24 episodes with Philips
18 episodes with Philips
18 episodes with Philips
12 episodes with Philips
10 episodes with Philips
16 episodes with Philips
5 episodes with Philips
23 episodes with Philips
15 episodes with Philips
5 episodes with Philips
6 episodes with Philips
8 episodes with Philips
8 episodes with Philips
7 episodes with Philips
4 episodes with Philips
8 episodes with Philips
9 episodes with Philips
6 episodes with Philips
116 episodes with Philips
5 episodes with Philips
7 episodes with Philips
23 episodes with Philips
7 episodes with Philips
109 episodes with Philips
6 episodes with Philips
7 episodes with Philips
6 episodes with Philips
10 episodes with Philips
6 episodes with Philips
5 episodes with Philips
5 episodes with Philips
6 episodes with Philips
15 episodes with Philips
5 episodes with Philips
7 episodes with Philips
7 episodes with Philips
5 episodes with Philips
11 episodes with Philips
2 episodes with Philips
4 episodes with Philips
16 episodes with Philips
4 episodes with Philips
5 episodes with Philips
6 episodes with Philips
4 episodes with Philips
6 episodes with Philips
5 episodes with Philips
4 episodes with Philips
4 episodes with Philips
7 episodes with Philips
4 episodes with Philips
4 episodes with Philips
4 episodes with Philips
7 episodes with Philips
15 episodes with Philips
2 episodes with Philips
6 episodes with Philips
5 episodes with Philips
3 episodes with Philips
4 episodes with Philips
4 episodes with Philips
6 episodes with Philips
4 episodes with Philips
4 episodes with Philips
5 episodes with Philips
4 episodes with Philips
7 episodes with Philips
7 episodes with Philips
4 episodes with Philips
3 episodes with Philips
2 episodes with Philips
5 episodes with Philips
5 episodes with Philips
4 episodes with Philips
3 episodes with Philips
3 episodes with Philips
3 episodes with Philips
3 episodes with Philips
2 episodes with Philips
3 episodes with Philips
3 episodes with Philips
3 episodes with Philips
3 episodes with Philips
5 episodes with Philips
4 episodes with Philips
4 episodes with Philips
4 episodes with Philips
9 episodes with Philips
4 episodes with Philips
6 episodes with Philips
6 episodes with Philips
3 episodes with Philips
3 episodes with Philips
4 episodes with Philips
2 episodes with Philips
2 episodes with Philips
3 episodes with Philips
7 episodes with Philips
2 episodes with Philips
4 episodes with Philips
2 episodes with Philips
11 episodes with Philips
2 episodes with Philips
3 episodes with Philips
3 episodes with Philips
2 episodes with Philips
What if CPAP isn't the only option for treating obstructive sleep apnea?In this episode of SleepTech Talk, we sit down with Eric Mongeau, Chief Commercial Officer at Daybreak, to discuss the growing role of oral appliance therapy in the treatment of obstructive sleep apnea (OSA).While CPAP remains the gold standard treatment for OSA, many patients are surprised to learn that oral appliance therapy can be an effective option for certain individuals. Eric explains how oral appliances work, who may benefit from them, and why having more treatment choices can help more patients achieve successful outcomes.We also explore how oral appliance therapy and PAP therapy can sometimes work together, creating personalized treatment plans that improve comfort, adherence, and long-term success.Key Takeaways:✅ Oral appliance therapy is a viable treatment option for obstructive sleep apnea✅ CPAP remains the gold standard therapy for OSA✅ Patients today have more treatment choices than ever before✅ The ultimate goal is effective treatment and better health outcomes✅ Oral appliance therapy can sometimes be used alongside PAP therapyWhether you're a sleep professional, DME provider, clinician, or someone living with sleep apnea, this episode offers valuable insights into the expanding landscape of sleep apnea treatment options.You can find Eric on LinkedIn and learn more about Daybreak at https://www.thedaybreak.com/A huge thanks to our sponsors:Philips Healthcare See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Fisher & Paykel Healthcare Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Soliish https://www.soliish.com/React Health https://www.reacthealth.com/myWaveshttps://mywaves.tech/More resources for clinicians can be found at Sleep Review Magazine https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 126The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Subscribe for more conversations with leaders shaping the future of sleep medicine, sleep technology, and patient care.#SleepApnea #DentalSleepMedicine #OralApplianceTherapy #CPAP #SleepTechTalk #SleepMedicine #SleepHealth #Dentistry #HealthcarePodcast #SleepDentistWe're turning the mic on ourselves for this episode of SleepTech Talk
Send us Fan MailIn the first part of our Best of Series, Caitlin Cooper and Angela Malik revisit some of the most powerful conversations we have had on psychological safety and high-performing teams.As we approach our 100th episode, this special round-up brings together insights from previous guests including Megan Giannini from Philips, Mike Wright from Network Rail, Laura McLean from Santander, Alex Myers, and Professor Adrian Furnham.Together, these conversations explore what psychological safety really means at work, why it is not about being nice all the time, and how it supports performance, learning, innovation, inclusion, and healthier challenge.From speaking up and listening up, to dealing with failure productively, measuring team climate, and creating environments where people can contribute honestly, this episode brings together the science, stories, and practical lessons that have shaped our thinking on psychological safety.Listen now to Best Bits: Driving High Performance Through Psychological Safety.Episodes are available here https://www.thecpo.co.uk/ To follow Zircon on LinkedIn and to be first to hear about podcasts, publications and news, please like and follow us: https://www.linkedin.com/company/betalent-by-zircon/ To access the research white papers mentioned in this and other podcasts, please go to: https://www.betalent.com/research For more information about the BeTalent suite of tools and platform please contact: Hello@BeTalent.com
Régi adósságát törleszti a Philips A Lenovo technológiája működteti a 2026-os Fifa világbajnokság™ rendszereit, és magasabb szintre emeli a mesterséges intelligencián alapuló közvetítést A vállalatok elvesztették a kontrollt az AI felett Mennyire lehet veszélyes az AI-fellendülés? A további adásainkat keresd a podcast.hirstart.hu oldalunkon. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Wer einen kompakten Zweitfernseher sucht, sollte sich dieses Lidl-Angebot genauer ansehen.
Steve Engelbrecht started Sitation from a rental apartment in Somerville, Massachusetts — five weeks after being laid off in the chaos that followed 9/11. Today it's a 62-person commerce enablement firm with a client roster of household names and a defensible niche the big SIs can't easily replicate.Recorded live at Salsify's Digital Shelf Summit in Atlanta, Christian sat down with Steve — founder and CEO of Sitation — for a conversation about building a services-plus-software business in commerce, how AI is rewriting the buy-vs-build equation, and why a 62-person specialist can out-maneuver Deloitte Digital and Accenture Song in product data.What we cover: The Sitation origin story and the early bet on PIM before it was a category, the three pillars of the business today (systems integration, managed services, and proprietary software), why the software-services convergence is playing out in real time, the "headless PIM in 2026" conversation with Salsify's CEO and what AI agents, MCP, and CLIs mean for the future of product data, how AI lowered the bar for participation and changed buy-vs-build, the Philips case study — a 111% conversion lift on a single SKU by optimizing content, not price, why 90%+ of Sitation's team came from industry and how that makes them stickier than the big SIs, and how Steve thinks about Sitation's future: international expansion as a platform vs. fitting neatly into a larger strategic's plans.⏱️ TIMESTAMPS0:26 — Welcome from Salsify's Digital Shelf Summit in Atlanta1:00 — The origin story: first day of work September 10, 2001, laid off five weeks later2:11 — Early to commerce enablement — and Boston as a commerce software hotbed3:02 — What Sitation does today: the three business segments5:25 — The 2019 "pick a lane" problem and why software-services convergence vindicated the strategy6:16 — How AI is changing the buy-vs-build equation7:36 — The "headless PIM in 2026" conversation with Salsify's CEO8:33 — Salesforce going headless and the new customization opportunity for SIs10:00 — APIs, the MCP revolution, CLIs, and why schema matters for AI agents11:05 — How a 62-person firm out-maneuvers multi-thousand-person SIs11:42 — Why this is a massive market, not a zero-sum game12:30 — The Philips case study: 111% conversion lift on one SKU without touching price13:30 — Why multinationals choose a boutique over Deloitte Digital or Accenture Song15:46 — The strategic question: platform play or acquisition target?16:29 — International expansion as the organic (or capital-backed) growth path17:40 — Why Sitation's platform credentials make it an attractive, hard-to-replicate target18:45 — Why you can't build Sitation's early-mover position — you have to buy it
Wie dacht dat het klaar was, komt van een koude kermis thuis. De slaapapneu-affaire is terug van weggeweest, met dank aan de Vereniging van Effectenbezitters. Komende donderdag stappen ze naar de Ondernemingskamer. Ze willen dat de rechter onderzoek doet naar alle problemen rond de slaapapneu-apparaten van Philips en of het bedrijf beleggers daar voldoende op tijd over heeft geïnformeerd. We blikken vast vooruit met Errol Keyner, adjunct-directeur van de VEB. In Beurs in Zicht stomen we je klaar voor de beursweek die je tegemoet gaat. Want soms zie je door de beursbomen het beursbos niet meer. Dat is verleden tijd! Iedere week vertelt een vriend van de show waar jouw focus moet liggen. Te gast: Errol Keyner van de Vereniging van Effectenbezitters BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.
Wie dacht dat het klaar was, komt van een koude kermis thuis. De slaapapneu-affaire is terug van weggeweest, met dank aan de Vereniging van Effectenbezitters. Komende donderdag stappen ze naar de Ondernemingskamer. Ze willen dat de rechter onderzoek doet naar alle problemen rond de slaapapneu-apparaten van Philips en of het bedrijf beleggers daar voldoende op tijd over heeft geïnformeerd. We blikken vast vooruit met Errol Keyner, adjunct-directeur van de VEB. In Beurs in Zicht stomen we je klaar voor de beursweek die je tegemoet gaat. Want soms zie je door de beursbomen het beursbos niet meer. Dat is verleden tijd! Iedere week vertelt een vriend van de show waar jouw focus moet liggen. Te gast: Errol Keyner van de Vereniging van Effectenbezitters BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.
WERBUNG | Spiele endlich im eigenen Team und werde gemeinsam mit WISO MeinBüro selbstständig! Mit unserem Code Beans50 sparst du dabei 50% auf das erste Jahr: [Link weiter unten]. Ob Rechnungen schreiben, Belege digital erfassen oder einfach um den Überblick zu behalten: WISO MeinBüro hält dir den Rücken frei! /WERBUNG Auf den furiosen Auftaktsieg von DEUTCHLAND folgt ein denkbar knapper Arbeitssieg gegen die ELFENBEINKÜSTE (COTE D'IVORE) - dem vermeintlich stärksten Gruppengegner. Nils Bomhoff, Etienne Gardé und Tobias Escher lassen das zweite deutsche Gruppenspiel der WM 2026 unmittelbar nach der Partie Revue passieren und sprechen über neue Erkenntnisse. Muss DENIZ UNDAV jetzt in die START-11? Wie krass ist bitte FELIX NMECHA?? Welche Gegner drohen dem DFB-TEAM in der KO-Phase und mit welcher Aufstellung sollte NAGELSMANN in das letzte Spiel gegen ECUADOR gehen? Viel Spaß bei der neuen Ausgabe des BOHNDESLIGA WM-STUDIOs! Rocket Beans wird unterstützt von Paulaner, Philips, WISO, XBOX-Snacks und dem XPERION Hamburg. Learn more about your ad choices. Visit megaphone.fm/adchoices
Nick and Dianna talking about Real-estate See omnystudio.com/listener for privacy information.
മെസ്സി , അവർ വിചാരിക്കുന്നത് അവർക്ക് നിന്നെ അറിയാമെന്നാണ് ദില്ലി -ദാലി പോഡ്കാസ്റ്റിലേക്ക് സ്വാഗതം അമേരിക്കൻ കവി Rowan Ricardo Philips ലയണൽ മെസ്സിയോടുള്ള ആദരസൂചകമായി 2019 ൽ The Paris Review ൽ എഴുതിയ ധ്യാനാത്മകമായ ആദരലേഖനത്തിന്റെ മലയാളം പോഡ്കാസ്റ്റ് രൂപം
'Physical AI' is de grote nieuwe trend waarbij artificiële intelligentie uit de digitale wereld stapt en redelijk letterlijk de fysieke wereld betreedt. Humanoïde robots dus, maar de definitie van physical AI blijkt veel breder te interpreteren. Het grote industriële concern Bosch springt er op en ziet er een nieuwe afzetmarkt in voor de maakindustrie. Dichter bij huis spreken we met de startup Aaltra die physical AI aanvliegt vanuit het perspectief van een eindgebruiker. In ‘Alles AI' hebben we het over Philips. Niet over hun scheerapparaten, maar zwel over hun medische CT-scanmachines en MRI's. Grote, vaak heel dure machines, waar ze dus kunstmatige intelligentie in steken. Waarom? Dat kom je in deze podcast te weten. Hosts: Kristof Van der Stadt en Els Bellens Productie: Jens Leen Hierover hadden we het onder andere in deze podcast: Bosch gooit zich als Europese technologiegigant voluit op physical AI VS beperken buitenlandse toegang tot AI-modellen Fable en Mythos van Anthropic ‘na gesprek met Amazon' Europese Commissie reageert op Amerikaans verbod rond Anthropic-modellen Grote cyberaanval op Oracle PeopleSoft-servers Hackerscollectief ShinyHunters claimt grootschalige diefstal van data bij Raad van Europa Trends is een podcastkanaal van de redactie van Trends.--- --- Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Zondag 14 juni 2026 Jaren 70 Jaren 70 (Polderman) Katinka Polderman 1'54 van de cd Andermans Veren 25 jaar CNR 22 515941 2 De jaren zeventig (fragment) (De Jonge) Freek de Jonge 1'38 Van de cd de Komiek Ariola 259.158 Elsje (Vermeulen/De Jonge) Neerlands Hoop 3'56 Van de cd Weerzien in Panama EMI 7 92456 2 Opa (Boerstoel/van Empelen) Don Quishocking 3'16 van de cd Dingen die je niet meer ziet Mercury 510 583-2 De appels op de tafelsprei (Hermans) Toon Hermans 4'24 van de Lp Onemanshow EME-Bovema 5C 194 25154/55 De reiziger (Zuiderveld) Rikkert Zuiderveld 4'07 Van de cd Parsifal EMI 7243 4 93786 2 9 De man die zelfmoord wilde plegen (Vleugel/Stokkermans) Jasperina de Jong 3'20 Van de cd De shows uit de jaren '70 EMI 7949422 Johanna (Elsink) Henk Elsink 6'32 Van de cd Een uur lachen EMI 7243 477698 2 5 Paal (I. de Wijs/P. Nieuwint) Kabaret Ivo de Wijs 2'42 Van de cd Terug naar de wortels EMI 8274002 Hare hare (J. Brink/A. Veen) Jos Brink 4'15 Van de LP Tekstpierement: Wit op Zwart Negram NR 105 Afscheid (Hogenkamp) Wim Hogenkamp 2'00 Van de Lp Heel gewoon Ariola 26 355 XOT Kees (H. Bannink/F. Halsema/M. v. d. Plas) Frans Halsema 3'53 Van de cd 1939-1984 Philips 824 193-2 Angst voor geluk (Wilmink/Bannink) Wieteke van Dort 2'35 Van de cd Het mooiste van Wieteke van Dort Mercury 586013-2 Zoek jezelf (G. Thomas/Heer Kooten/heer Bie) Van Kooten en de Bie 3'40 Van de cd De eerste langspeelplaat van het Simplistisch Verbond SVCD 1
Hosts Jim DeRogatis and Greg Kot talk with music journalist and author Barry Walters about his new book Mighty Real: A History of LGBTQ Music 1969-2000. They discuss how gay artists, industry execs and audiences changed mainstream music. They also chat about artists like R.E.M., Pet Shop Boys, Donna Summer and more.Join our Facebook Group: https://bit.ly/3sivr9TBecome a member on Patreon: https://bit.ly/3slWZvcSign up for our newsletter: https://bit.ly/4frcVZoMake a donation via PayPal: https://bit.ly/3dmt9lUSend us a Voice Memo: Desktop: bit.ly/2RyD5Ah Mobile: sayhi.chat/soundops Featured Songs:David Bowie, "Rebel Rebel," Diamond Dogs, RCA, 1974The Beatles, "With A Little Help From My Friends," Sgt. Pepper's Lonely Hearts Club Band, Parlophone, 1967Sylvester, "You Make Me Feel (Mighty Real)," Step II, Fantasy, 1978Pet Shop Boys, "Opportunities (Let's Make Lots of Money)," Please, Parlophone, 1986R.E.M., "Pretty Persuasion," Reckoning, I.R.S., 1984Gang of Four, "Call Me Up," Songs of the Free, EMI, 1982Prince, "Controversy," Controversy, Warner Bros., 1981Grace Jones, "Warm Leatherette," Warm Leatherette, Island, 1980Laura Nyro, "Stoned Soul Picnic," Eli and the Thirteenth Confession, Columbia, 1968Donna Summer, "Queen For a Day," Once Upon a Time, Casablanca, 1977Indigo Girls, "Closer to Fine," Indigo Girls, Epic, 1989Michael Jackson, "Childhood," HIStory: Past, Present and Future, Book I, Epic, 1995The Smiths, "There Is a Light That Never Goes Out," The Queen Is Dead, Rough Trade, 1986David Bowie, "Space Oddity," David Bowie, Philips, 1969Frankie Goes to Hollywood, "Relax," Welcome to the Pleasuredome, ZTT, 1984Robyn, "Blow My Mind," Sexistential, Konichiwa and Young, 2026See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hoving Home will reroute, widen waterway The Philipstown Conservation Board determined on Tuesday (June 10) that there would be no significant environmental impacts if the Hoving Home removes a dam and reroutes a section of Philips Brook that runs through its property in Garrison. The board's vote concluded the environmental review for the $1.8 million project, under which the treatment program for women plans to remove a 10-foot-high dam originally built decades ago to create a swimming pond. It will then move 800 feet of the brook north into a new 30-foot-wide channel that will be 3 to 5 feet deep, enabling it to hold more water. Some sections of the stone wall constraining the brook as it flows west to Constitution Marsh will be removed, as will one of the footbridges and one of three lower dams, or weirs. Dirt excavated for the new channel will be used to fill 300 feet of the brook and the two other weirs. Despite multiple repairs, the dam and the stone walls have sustained extensive damage from flooding and face greater water pressure as storms intensify and become more frequent, according to Inter-Fluve, the Cambridge, Massachusetts, firm overseeing the project. If the dam failed, the rush of water could damage downstream properties, creating a liability risk for the Hoving Home, said Nick Nelson, a fluvial geomorphologist with Inter-Fluve who reviewed the project during a Conservation Board public hearing last month. The project is also expected to improve passage for fish and other aquatic species and reduce flooding along Snake Hill Road. "There's water still flowing through, but what used to be a pond is filled with gravel and cobble," said Nelson. "If that dam were to fail catastrophically during a storm, all of that material would be washed downstream." Hoving Homes submitted an application for a wetlands permit in June 2025. After neighbors raised concerns about potential flooding, the board asked its consultant, SLR Engineering, to review Inter-Fluve's projections. SLR found Inter-Fluve's modeling to be adequate. The Conservation Board, which still must issue a wetlands permit, concluded that the Hoving Home had taken steps to reduce temporary "moderate-to-large impacts" related to drainage, erosion and flooding during construction. Beth Greco, the Hoving Homes president and CEO, said it plans to begin the project in the spring. Under a permit approved by the state Department of Environmental Conservation, Hoving will be prohibited from undertaking in-stream work from Oct. 1 to April 30, when trout spawn and incubate. Once finished, the new channel will be wider and shallower than the existing one. Boulders will be placed along its bed to create "step pools" — areas of deeper water to slow the flow and reduce erosion of the banks. The pools also provide "resting stops" for fish and oxygen-rich water during periods of turbulence, according to Inter-Fluve. Native plants will cover the new bank. In addition, according to Inter-Fluve, the reconstruction will avoid two areas of "archeological sensitivity" identified in consultation with the state Historic Preservation Office, which considers the site eligible for the National Register of Historic Places. The configuration will send "additional flow" through a culvert that carries the brook under Avery Road, according to project documents. Walter Hoving received a $200,000 grant to replace the town-owned culvert, which is considered undersized. But Greco said last month that the property lines bordering the culvert prevent it from being widened. "It's in good enough shape to keep," she said.
Con una mossa che ci sorprende solo relativamente, Microsoft ha vietato di usare il nuovo controverso modello Ai, ecco perché. OpenAI studia le contromisure per arginare la concorrenza. Philips lancia una curiosa nuova lampada. La verità sul Trump phone. Learn more about your ad choices. Visit megaphone.fm/adchoices
This episode covers: Cardiology This Week: A concise summary of recent studies Transcatheter treatment of tricuspid regurgitation Carcinoid heart disease Milestones: MADIT-II Trial Host: Wilfried Mullens Guests: Stephan Baldus, Heidi Connolly and Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2560 Want to watch that extended interview on transcatheter treatment of tricuspid regurgitation, go to: https://esc365.escardio.org/event/2560?resource=interview Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Heidi Connolly, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Host: Wilfried Mullens Guest: Stephan Baldus Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560 Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Ken je 'm nog, die allereerste aflevering van Masterminds? Het was september 2020, volop corona. Dus misschien heb je 'm wel gemist… In deze Masterminds-aflevering duiken Kees en Botte in het leven van de grote componist Ludwig van Beethoven. Ze bespreken zijn jeugd, het norse karakter van de componist en wat zijn naderende doofheid betekend heeft voor zijn muziek. Fragmenten: Symfonie nr. 2 en 3: Hanover Band; Nimbus Records NI 5144-48; Wellingtons Sieg: Academy of St. Martins; Universal Records 00028942623927; Strijkkwartet op. 135: Guarneri Quartet; Brilliant Classics 93525/40; Pianoconcert nr. 5: Alfred Brendel, London Philharmonic; Philips 422 937-2
Steve Caplin is not willing to stump up £650 for Lego's tallest model, Gaudi's Sagrada Familia. Nor is he likely to buy a souped-up version of a 1960s Ford Escort for £300,000. There's a surgical robot that works inside you which is the size of a seed. Philips has come up with dual-sided monitors to check that your hotel bill is correct. The results of a psychological survey of the problems of life on the moon won't surprise anyone. Schiphol Airport plans to use TaxiBots to take planes to their takeoff spot. The D4RYL humanoid magician has been barred from joining the Magic Circle. And phone chargers from Amazon and eBay can explode, according to Which? Learn more about your ad choices. Visit podcastchoices.com/adchoices
BONUS: Why More Code Doesn't Mean Better Software — And Where AI Actually Helps Your SDLC Most teams are adopting AI to write code faster. But what if code generation isn't your bottleneck? Mooly Beeri has spent 25 years diagnosing where software organizations actually underperform — from Microsoft to Philips to automotive — and his message is clear: measure before you automate, and tie every AI investment to a business KPI. The Pattern Debugger's Origin Story "I've been identifying patterns way before AI was doing that. One of my first jobs was Microsoft, and I got the opportunity to work in engineering excellence. Every single simple improvement would make the lives of so many people better and the code better and the products better." Mooly's career started at Microsoft in engineering excellence, where he discovered his passion for finding process areas that need improvement. From there he built the first software centre of excellence for Philips, spawned it into a separate business, and has been doing the same process excellence work across healthcare, telecom, and automotive ever since. His framework: understand where you're bleeding quality, revenue, or budget — then intervene there, not everywhere. Improvement Doesn't Mean Progress "There are too many efforts to improve too many things that don't really matter. The ability to tie a specific improvement to what actually means progress for a business — that, for me, is one critical component that's missing in many transformations." Mooly's core insight applies directly to AI adoption: everyone has an improvement plan, but few can answer "how does this improvement improve business performance?" If you ask that one additional question, you can probably cancel half your improvement projects — the ones that make people feel good but don't move the needle on time to market, quality, or cost. The Code Generation Trap "It's like saying a book author is more productive because they write more words. The unit of work is not the number of lines of code they produce. The unit of work is a piece of code that works, that is tested, that is fully reliable, that meets a customer expectation, and eventually generates revenue." Data from Faros AI shows individual developer PRs went up 98% with AI tools — but organizational delivery actually dropped 1.5%. More code, same or worse outcomes. Mooly explains why: most organizations invest in code generation not because it's the most effective thing to improve, but because it's the easiest step to automate. There are 35 steps in the SDLC. Picking code generation gives you a 1-in-35 chance of striking gold. As the saying goes: hope is not a strategy. Where AI Actually Works in the SDLC "The best usages would be in areas of the SDLC where there is a lot of data that needs processing and needs some detection of patterns — where AI is really, really good." The most successful AI applications Mooly has seen with clients: Defect root cause analysis — training AI agents on thousands of Jira bugs to find patterns humans can't see. In one healthcare client, AI analysis revealed that "false positive" bugs were actually compromised requirements — the dev team was closing real deviations as unimportant because they didn't have time to fix them Code review enhancement — AI scans incoming defects and generates a live, evolving checklist so reviewers spend their limited time checking for the most probable problems Test generation — unit, component, and functional test creation where AI can leverage existing test patterns and requirement data Requirements review — correlating requirements against strategic objectives, OKRs, and historical defect patterns to find contradictions before coding begins The Thinking Process You Can't Automate "The developers going through the process of converting requirements into code — it's actually a thinking process. It creates a lot of discussions with the product managers, a lot of back and forth, which help refine the requirement. This entire exchange is gone out the window when you have AI generate the code in 5 minutes." When AI generates code instantly from requirements, it eliminates the human feedback loop that catches contradictions and incomplete specifications. The FDA has recognized this: every AI-assisted step in medical device software must be guardrailed by human activity. If you generate code quickly but still need a human review, the speed gain disappears. The value of coding was never just the code — it was the thinking. Map Every Investment to a Business KPI "If your uncle ran a bicycle repair shop and you said, let's advertise in the local newspaper, the first question he'd ask is: how many new customers will we get? The business logic hasn't evolved so much. If you want to do something — how will this impact your revenue, your customer retention, or your cost of producing goods? If you can't answer these things, don't invest." Mooly's advice is deceptively simple: before adopting any AI tool in your SDLC, ask yourself which of three business outcomes it will improve — faster time to market, higher quality (fewer customer issues), or better margins (lower execution cost). If you can't draw a direct line from the AI investment to one of those outcomes, you're doing improvement theatre. About Mooly Beeri Mooly Beeri is CEO and co-founder of BetterSoftware, a consulting firm with over 25 years helping companies across healthcare, telecom, and automotive transform how they build software. His work focuses on diagnosing where software organizations underperform and designing targeted interventions — not blanket transformations. You can link with Mooly Beeri on LinkedIn.
In de Bright Podcast hebben we het deze week uitgebreid over WWDC26 en de nieuwe Siri AI en waarom die voorlopig nog niet op een iPhone is te gebruiken in Nederland. Verder in deze aflevering: de nieuwe 'dakraam-lamp' van Philips en waarom de slimme speakers van Google plotseling overal zijn uitverkocht. Ook kijken we naar de nieuwste AI van Anthropic en een onafhankelijk onderzoek dat gehakt maakt van de beloofde terugverdientijd van thuisbatterijen. Partner: Europarlementariër Kim Van Sparrentak neemt het op tegen de techbro’s om duidelijke regels te maken voor kunstmatige intelligentie. Luister de podcast Red de AI Wet in alle podcast-apps. Tips uit deze aflevering: Serie: Erwin heeft Euphoria S3 afgekeken op HBO Max, sterk slot van een baanbrekende serie. En hij geniet van Star City op Apple TV (Das Leben der Anderen vibe) en van Clarkson’s Farm S5 op Prime Video. Serie: Widow’s Bay op Apple TV is inderdaad geweldig, Erwin tipte het twee weken geleden al. Het is een serie in de vreemde traditie van Twin Peaks: mysterieus maar ook wel grappig. De balans is alleen heel knap gedaan. De hoofdrolspeler is de burgemeester van een eiland, een beetje een sukkel die het toerisme wil opkrikken. Alleen het eiland zelf lijkt dat niet te willen, en dan komt hij steeds oprecht griezelige, bovennatuurlijke dingen tegen. Het zit vol met hommages naar klassieke horrorfilms, en is bij vlagen ook echt eng, maar dan toch weer grappig omdat je weet dat die oen zich in allerlei bochten wringt omdat bovennatuurlijke weg te wuiven, want hij wil toeristen. Podcast: En dan ook nog een van de nieuwste afleveringen van The Rewatchables, een podcast waarin ze klassieke films nabespreken met bekende mensen. Deze tip gaat over de aflevering over 2001: A Space Odyssey, met als gast niemand minder dan Steven Spielberg. Zijn nieuwste film, Disclosure Day, draait vanaf deze week in de bioscoop. Spielberg is ruim twee uur te gast om te praten over de film van Kubrick, maar natuurlijk komen ook zijn eigen films en allerlei boeiende verhalen langs. Heel leuk om Spielberg zo tussen twee andere filmliefhebbers te horen. App: Grug, een simpele app van Nederlandse makelij die een Apple Design Award heeft gewonnen. Een soort dagboek als geen ander, een toegankelijke manier om je hoofd leeg te maken, een app die niet moet maar juist mag.See omnystudio.com/listener for privacy information.
Philips North America is launched its 11th annual Future Health Index, focused this year on how AI is being used in real-world healthcare settings. Jeff DiLullo, Philips’ North America chief region leader, argues that AI is moving beyond a cost-cutting story and starting to change how doctors work, how hospitals manage capacity and how patients experience care. He speaks with Bloomberg's Carol Massar and Emily Graffeo. See omnystudio.com/listener for privacy information.
Se você já se perguntou como nasceram os termos "Pai do Bebê", "Tio do Bebê", "Ex-Grá" e toda a tour que tomou conta da internet, chegou a hora de descobrir a história completa!Neste episódio do PodDelas, Amanda Araújo e Eduardo Daibert contam como uma simples piada de família virou um dos maiores fenômenos espontâneos das redes sociais brasileiras. O papo foi leve sobre infância, família, fama, maternidade, a chegada do Richarlison Jr., os bastidores da relação com Richarlison e como a internet transformou a vida deles em uma verdadeira sitcom da vida real.Além disso, tem muitas histórias inéditas, momentos engraçados, e uma dinâmica especial que vai render boas risadas.Dá o play para conhecer os bastidores da família que conquistou a internet sem nem perceber. E, claro, se inscreve no canal.#PodDelas #AmandaAraujo #EduardoDaibert #Richarlison #PaidoBebê #TiodoBebê #ExGra #RicharlisonJr #Podcast #PodDelasPodcast______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo
Most employees spend their careers feeling confused about compensation, how it works, what’s negotiable, and what’s actually going on behind the scenes. In this episode, Sandrine Bardot breaks down how salaries are actually set, what professionals consistently get wrong about negotiation, and why the psychology of pay matters more than most people realise. From how companies build and allocate salary budgets to the best moments in your career to push for more, to the concept of procedural justice and why it shapes whether employees accept or reject pay decisions, this is the compensation conversation most workplaces never have. Our Guest: Sandrine Bardot Sandrine Bardot is a senior Performance and Reward advisor, founder of The Bardot Group, and a Transformational Performance and Reward Architect working at the intersection of strategy, governance, executive compensation, performance, and human capital. With more than 30 years of experience mostly across EMEA, including over a decade advising organisations across the Middle East, Sandrine brings deep technical reward expertise, corporate leadership experience, regional judgement, and Board-level advisory perspective. She advises Boards, Nomination and Remuneration Committees, CEOs, CHROs, Heads of Total Rewards, family business leaders, and senior decision-makers on the performance and reward systems behind strategy execution. Her work spans executive and Board remuneration, incentives, reward governance, performance management, job architecture, pay equity and transparency, nationalisation- linked reward design, pre-IPO readiness, and the modernisation of legacy reward models. Before founding The Bardot Group, Sandrine held senior Performance and Reward roles at Majid Al Futtaim and Mubadala, and worked with organisations including Apple, Microsoft, Airbus, Philips, and Fiat. She is known for her candour, cultural intelligence, and ability to help organisations design reward systems that are practical, explainable, governable, and defensible under scrutiny. References: Sandrine Bardot LinkedIn profile Listen to the next Episode All Podcast Episodes
Ela é influenciadora, empresária, mãe da Helena e do Matteo, está grávida do terceiro filho e vive uma das fases mais especiais da sua vida. Neste episódio, o PodDelas, recebe Tainá Militão! Tainá fala sobre maternidade, família, casamento, mudanças, carreira, gravidez, a vida entre Brasil e Espanha e os bastidores de uma rotina que milhões de pessoas acompanham pelas redes sociais.E mais: conta como surgiu a paixão por perfumes e revela detalhes da criação da sua primeira fragrância em parceria com a Pétala Beauty.Não dá pra perder, né?Uma conversa leve, emocionante e cheia de histórias que você ainda não conhecia. Dá o play e vem curtir! Ah, e se inscreve no canal! #PodDelas #TainaMilitao #TainaCastro #EderMilitao #Maternidade #Gravidez #PétalaBeauty #Convocadas #Podcast______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo
Ela abriu caminhos quando o futebol feminino ainda nem tinha espaço.É a eterna “Rainha das Embaixadinhas”, jogou na Europa, viveu os bastidores de algumas das maiores Copas do Mundo da história e acompanhou de perto uma das eras mais marcantes do futebol brasileiro.Neste episódio, o PodDelas recebe Milene Domingues para uma conversa sobre futebol, maternidade, carreira, Copa do Mundo e evolução do futebol feminino. Um episódio sobre legado, força, recomeços e uma história que vai muito além do que o público conheceu pela televisão.INSCREVA-SE NO CANAL PARA CHEGARMOS A 4MI DE INSCRITOS!#PodDelas #MileneDominggues #CopaDoMundo2026 #FutebolFeminino #Ronald #RonaldoFenomeno #SeleçãoBrasileira #CorinthiansFeminino #RainhaDasEmbaixadinhas______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo
Operadores móviles vinculan líneas sin consentimiento, mientras usuarios se amparan contra el registro telefónico, a unos días del Mundial, integrantes de la CNTE derriban estatuas en Reforma y anuncian extensión de plantón y la inteligencia artificial abre a México una oportunidad de 18,000 millones de dólares, con Puri Lucena y Mara Echevarría.00:00 Introducción01:28 Operadores móviles aceleran la vinculación de líneas celulares sin consentimiento de usuarios06:09 Integrantes de la CNTE derriban estatuas mundialistas en Reforma13:01 La IA redibuja la inversión mundial y abre a México una oportunidad de 18,000 mdd16:57 Prohibición de comida chatarra en escuelas estanca recaudación del IEPS21:04 9 de cada 10 TV que Philips venda para el Mundial estarán hechas en México
Do This, NOT That: Marketing Tips with Jay Schwedelson l Presented By Marigold
Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤEver asked an AI tool to explain your own company and cringed at how wrong it got things? This week there's a genuinely simple fix for that, and Jay Schwedelson lays it out in a way that turns those AI answers into a ready-made content plan. He somehow gets there by way of a hospital collab and a four-dollar Instagram upgrade he's weirdly excited about, which tells you everything about how this one flows.ㅤBest Moments:(00:16) Disney teams up with Philips to surround kids with ambient Disney characters during their MRIs(01:36) The gut-punch stat, 88 percent of CMOs are getting grilled on AI visibility while most have no plan(02:06) Most marketers have already caught AI describing their company completely wrong(03:40) Ask all four AI tools the same question, then build content around the answers they all share(04:52) Meta's new Instagram add-on lets your stories outlive the 24-hour cutoff, and Jay thinks it's worth it(06:45) The Eventastic pitch arrives with DJs, a cannonball guy, and a Taylor Swift dance contest
On today's episode, Philips's chief medical officer Carla Goulart Peron shares how artificial intelligence is reshaping health care — not by replacing clinicians but by expanding access, improving diagnostics, and freeing doctors to focus more time on patients. Drawing on her experience practicing medicine in Brazil's strained public health system, she explains how technologies like AI-assisted imaging and remote collaboration can bridge critical gaps in care. Carla also explores the challenges of trust, bias, interoperability, and women's health data in the next era of AI-enabled medicine. She offers a grounded, global perspective on how technology can make health care more human. Read the episode transcript here. Guest bio: Dr. Carla Goulart Peron is chief medical officer at Philips. A physician by training, she leads the global team shaping the health technology company's medical strategy for achieving scientific excellence across medical affairs, clinical research, medical safety, and health economics. Before joining Philips, she was vice president and chief medical officer for surgical innovations and robotics at Medtronic. Me, Myself, and AI is a podcast produced by MIT Sloan Management Review and hosted by Sam Ransbotham. It is engineered by David Lishansky and produced by Allison Ryder. We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials. ME, MYSELF, AND AI® is a federally registered trademark of Massachusetts Institute of Technology. All rights reserved.
Sleep apnea treatment isn't one-size-fits-all—and CPAP isn't the only option.In this episode of SleepTech Talk, we sit down with Dr. Suzanne Thai, DDS, TEDx speaker, dental sleep medicine specialist, and one of the leading voices in dental sleep medicine on social media. Dr. Thai shares how oral appliance therapy is helping patients find effective treatment for sleep apnea and why collaboration between sleep physicians and sleep dentists is critical for patient success.Whether you're a sleep professional, healthcare provider, or someone living with sleep apnea, this conversation offers valuable insight into treatment options that extend beyond traditional CPAP therapy.Key topics include:✅ Why oral appliance therapy can be a first-line treatment for obstructive sleep apnea—not just an alternative to CPAP✅ How oral appliances and CPAP therapy can work together to improve treatment outcomes✅ What makes a sleep dentist different from a general dentist✅ How dental sleep medicine specialists collaborate with sleep physicians to provide comprehensive patient care✅ Common misconceptions about oral appliance therapy and who may benefit mostDr. Thai brings a unique perspective as a clinician, educator, TEDx speaker, and influential advocate for sleep health. Her passion for improving patient outcomes and increasing awareness of dental sleep medicine shines throughout this episode.You can learn more about Dr Suzanne Thai here:Her TEDx talk on Youtube: https://youtu.be/J1xRI199RUo?si=5E69LZ9BXhh9koUNYoutube: @DrSuzanneThaihttp://www.youtube.com/@DrSuzanneThaiInstagram: @Dfwsleepsolutions instagram.com/dfwsleepsolutionsFacebook:facebook.com/dfwsleepsTikTok:https://www.tiktok.com/@drsuzannethai?_r=1&_t=ZT-96mScoLxZJlA huge thanks to our sponsors:Philips Healthcare See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Fisher & Paykel Healthcare Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Soliish https://www.soliish.com/React Health https://www.reacthealth.com/myWaveshttps://mywaves.tech/More resources for clinicians can be found at Sleep Review Magazine https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 125The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Subscribe for more conversations with leaders shaping the future of sleep medicine, sleep technology, and patient care.#SleepApnea #DentalSleepMedicine #OralApplianceTherapy #CPAP #SleepTechTalk #SleepMedicine #SleepHealth #Dentistry #HealthcarePodcast #SleepDentist
Your podcast pilots have turned on the fasten seatbelt sign. Please remain seated as we deal with the audio turbulence that is the Verbal Shenanigans podcast. Your in flight entertainment is an interview with Noel Philips. Noel is a travel content creator who has traveled the world on every plane, train, bus throughout the world. We chat on the business and angst of world travel, the time and money needed, and a chance encounter on a flight that saved his life. Enjoy this with your in flight meal. We also welcome our newest sexy follower, Scott has an insane lawnmower story, and Mike visits and feeds alpacas with his mouth. A great week of nonsense on Verbal Shenanigans. Have a listen!
This episode covers: Cardiology This Week: A concise summary of recent studies The heart in high altitude Mitral annular disjunction Mythbusters: Weekend mortality Host: Rick Grobbee Guests: JP Carpenter, Kristina Haugaa, Silvia Ulrich Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Want to watch that extended interview on mitral annular disjonction, go to: https://esc365.escardio.org/event/2563?resource=interview Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Silvia Ulrich have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Host: Rick Grobbee Guest: Kristina Haugaa Want to watch that extended interview on https://esc365.escardio.org/event/2563?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Wie knackt man einen Markt, der seit Jahrzehnten von zwei Giganten beherrscht wird? Stefan Walter, Gründer des Zahnpflege-Startups Happybrush, hat es mit Oral-B und Philips aufgenommen und macht heute Umsätze im zweistelligen Millionenbereich. Im OMR Podcast gibt er Einblicke in seine Reise von Procter & Gamble zum erfolgreichen Entrepreneur. Er erklärt, wieso eine schwarze elektrische Zahnbürste anfangs eine Revolution im Drogerie-Regal darstellte, was der Auftritt bei "Die Höhle der Löwen" gebracht hat, wie lukrativ das Abo-Modell mit elektrischen Zahnbürsten ist und welche Rolle Testergebnisse auf dem Zahnpflegemarkt spielen.
In this episode digital optimist, author, and global business executive Chris White joins the show to discuss his expansive 30-year career trajectory, notably highlighting his two decades at Cisco during its monumental growth from $1 billion to $50 billion. Drawing from deep, lived experiences in Silicon Valley and leadership structures across the globe, he breaks down the core concepts of his new book, Non-Optional Collaboration: Aligning Cross-Functional Teams Across Cultures. From drawing parallels between the high-stakes synchronisation of rowing sports to navigating corporate silos, psychological safety, and the "mushy middle" of organisational talent, this conversation delivers an essential blueprint on leveraging modern human leadership alongside AI to unlock maximum team output. You'll Learn Why: True operational synchronisation mimics the sport of rowing, where individual execution must flawlessly align without substitution to move the entire vessel forward. Actively motivating and engaging the "mushy middle"—the 80% of talent sitting between your top and bottom performers—is the ultimate way to drastically scale your business. Leaders inadvertently damage psychological safety when they visually assert themselves as the smartest person in the room rather than facilitating group intelligence. High-fidelity physics metrics are crucial, but sustainable organisational success requires building active, programmatic feedback debriefs modelled after elites like the Blue Angels. This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit https://brave-bold-brilliant.com/ for free tools, guides and resources to help you take action now
Lessons from Sleep Experts: What We Learned From Our Biggest SleepTech Talk EpisodesIn this special host-only episode of SleepTech Talk, we take a step back to reflect on some of our biggest conversations, most impactful guests, and the incredible response from listeners across the sleep medicine community. From episodes that reached hundreds of thousands of views to conversations that challenged the way we think about patient care, technology, obesity medicine, diagnostics, and the future of sleep health, this episode highlights the key lessons we've learned along the way.We discuss the common themes that continue to emerge from our guests: the importance of patient-centered care, innovation in sleep medicine, collaboration across specialties, and the growing awareness of how sleep impacts overall health.We also preview several major upcoming events in the sleep industry, including SLEEP 2026, Current Concepts in Sleep 2026, and the Carolinas Sleep Society 2026 Conference. If you'll be attending, come meet the SleepTech Talk hosts in person and join the conversation about the future of sleep medicine.Key TakeawaysSeveral SleepTech Talk episodes generated hundreds of thousands of views and sparked meaningful industry conversationsEvery guest brought unique insights that continue to shape the future of sleep medicine and patient careThe sleep community continues to evolve through collaboration, education, and innovationWe're excited to connect with listeners and industry professionals at upcoming 2026 sleep conferencesA huge thanks to our sponsors:Philips Healthcare See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Fisher & Paykel Healthcare Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Soliish https://www.soliish.com/React Health https://www.reacthealth.com/myWaveshttps://mywaves.tech/More resources for clinicians can be found at Sleep Review Magazine https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 124The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.
Ik ben een fantastische spits, maar mijn team gaat wel verliezen. Dat is vrij vertaald wat de altijd amusante Michael O'Leary van Ryanair zegt over zijn vliegtuigmaatschappij en de concurrentie. Hij heeft het 'Armageddon'-scenario klaarliggen nu de oorlog in Iran alweer zijn derde maand af dreigt te sluiten. Zelf gaat hij niet kopje onder door die hoge brandstofprijzen (nee hoor), maar er gaan mogelijk wel een paar concurrenten sneuvelen... Iets koopwaardiger, althans volgens de financiële markten: groene energie. Wablief? Ja ja, de woorden 'winst' en 'windmolen' stonden de afgelopen jaren zelden in dezelfde zin. Toch is de index voor groene energie-aandelen met een opmars bezig. Bedrijven als Ørsted en Vestas hebben de wind weer in de rug vanwege de oorlog in Iran én de energieveelvraat die AI heet. Maar betekent dat ook dat deze bedrijven straks veranderen in echte GE Vernova's, of kan een windmolen zich niet meten met een gasturbine? We bespreken de ins & outs. Verder praten we je bij over een monsterdeal die de VS het grootste nutsbedrijf op aarde oplevert, over ASML dat India gaat helpen om een chipindustrie op te bouwen en natuurlijk de stakingen bij Samsung die de hele chipketen hoofdpijn dreigen te geven. Te gast: Justin Blekemolen, analist bij online broker Lynx BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.
Healthcare is undergoing a serious transition away from hardware-centric systems toward software-defined and physical AI-enabled healthcare environments. Healthcare is also moving toward a paradigm that is proactive, personalized, and ambient, leveraging intelligent technologies to improve patient care, operational efficiency, and clinical outcomes. The conversation explores how technologies such as advanced diagnostics, surgical robotics, remote monitoring, and smart medical devices are reshaping healthcare delivery. Gopal also shares practical insights into the challenges the industry faces around regulation, cybersecurity, data interoperability, verification and validation, and operational transformation. Most importantly, the discussion highlights how healthcare is gradually moving from reactive treatment models toward more proactive, personalized, and patient-centric care by 2030. This is a valuable conversation for healthcare leaders, technology executives, and anyone interested in the future of healthcare innovation. Watch this insightful interaction Ramachandran S, HFS Research, had with Gopalratnam VC, Executive Vice President and Global CIO at Philips, on the move toward software-defined healthcare. Key TakeawaysSoftware is becoming the key differentiator in modern medical devices. Intelligent systems and robotics are improving precision and operational efficiency in healthcare. Verification, validation, and compliance remain critical in healthcare technology adoption. Data fragmentation and lack of interoperability continue to slow innovation across healthcare ecosystems. The healthcare industry is moving toward more proactive and preventive care models. Personalized healthcare experiences will become increasingly important by 2030. Automation can help reduce administrative burdens for clinicians and healthcare staff. Future healthcare systems are expected to become more connected, efficient, and patient-focused.
This episode covers: Cardiology This Week: A concise summary of recent studies Biomarkers in heart failure Digoxin in HFrEF Scientific Highlights from Heart Failure 2026 Host: Wilfried Mullens Guests: Lynne Stevenson, Dirk van Veldhuisen, Theresa McDonagh Want to watch that episode? Go to: https://esc365.escardio.org/event/2565 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. A ny views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Dirk van Veldhuisen and Lynne Warner Stevenson have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report:Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Theresa McDonagh has declared to have potential conflicts of interest to report: honoraria from Boeringer Ingelheim. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Healthcare innovation is at its best when it takes on hard problems with curiosity, humility, and a clear-eyed focus on impact. In this episode, Betsabeh Madani-Hermann, Global Head of Research at Philips, shares how complexity drives her passion for healthcare innovation. As the first female head of research in the company's 135-year history, she leads breakthrough technologies and global partnerships to simplify care and scale impact. She explains how Philips' innovation DNA helps move ideas from early exploration to real-world application. Betsabeh also highlights the use of pre-mortems to anticipate risks and emphasizes that the future of healthcare will be shaped by more than AI, including robotics, imaging, and human curiosity. Tune in and learn why the best innovations come from staying curious, solving difficult problems, and preparing honestly for what could go wrong. Resources: Connect with and follow Betsabeh Madani-Hermann on LinkedIn. Follow Philips on LinkedIn and explore their website!
Oral Arguments for the Court of Appeals for the Fifth Circuit
Philips North America v. Image Tech Conslt
"Philips kwam onlangs op een ranglijst naar voren als het meest toekomstbestendige bedrijf van Nederland", vertelt Thomas Pellegrom van ABN Amro, daarbij aantekenend dat healthcare het altijd goed doet op die lijsten. "Los daarvan zijn de cijfers oké. Orders stegen met 6 procent, de omzet met 4 procent. Ze handhaven de guidance, wat neerkomt op 3 à 4 procent omzetgroei en 12 tot 13 procent EBITDA-marge. Vooral de consumentendivisie doet het goed." Ook Richard de Jong van Van Lieshout & Partners vindt de cijfers prima, maar is Philips het meest toekomstbestendige bedrijf van Nederland? "Het is in ieder geval zo dat het niet meer zo achterblijft op concurrent Siemens Healtineers. Een koerswinstverhouding van 15, dat is eigenlijk een prima instapniveau als je de aandelen nog niet hebt." De AEX wist deze week weer een nieuwe all time high neer te zetten. Ook veel andere indices bereikten recordhoogten. Dat lijkt vreemd, maar wie kijkt naar de bedrijfswinsten en de vooruitzichten van bedrijven, kan niet verrast zijn. Dat weegt voor beleggers duidelijk zwaarder dan de onzekerheid omtrent de oorlog in het Midden-Oosten. Echter, duurt die oorlog veel langer dan nu verwacht, dan zal dat ongetwijfeld effect hebben op de koersen. Verder in de podcast aandacht voor onder andere de cijfers van Shell, Adyen, Uber en chipmaker AMD. Natuurlijk behandelen we de luisteraarsvragen en krijg je de tips. Thomas tipt een ETF met de ISIN-code IE00BJ5JNY98, Richard tipt een groot energieconcern. Geniet van de podcast! Let op: alleen het eerste deel is vrij te beluisteren. Wil je de hele podcast (luisteraarsvragen en tips) horen, wordt dan Premium lid van BeursTalk. Dat kost slechts 9,95 per maand, 99 euro voor een heel jaar. Abonneren kan hier! VanEck ETF’s (advertorial) Deze week is ook weer het tweewekelijks gesprek te beluisteren met Martijn Rozemuller, ceo van VanEckETF’s, de partner van BeursTalk. In deze aflevering praat ik met Martijn over de onlangs gelanceerde VanEck Morningstar Developed Markets ex-US Dividend Leaders ETF, en we behandelen meteen een luisteraarsvraag die over deze ETF is binnengekomen.Het is een trend die al een tijdje gaande is: nogal wat beleggers willen tegenwoordig wat minder blootstelling aan de VS. Ook van klanten kreeg Martijn regelmatig te horen dat ze minder in Amerikaanse aandelen wilden beleggen. Niet gek dus dat VanEck met deze nieuwe VanEck Morningstar Developed Markets ex-US Dividend Leaders ETF zijn klanten die optie aanbiedt. Martijn legt uit wat de overige verschillen zijn met de al bestaande hoog dividend-ETF, naast het feit dat deze ETF niet in de VS belegt. Denk daarbij bijvoorbeeld aan de andere regio's buiten Europa en de verdeling over de verschillende sectoren waarin de nieuwe ETF belegt. Toevallig of niet, over de VanEck Morningstar Developed Markets ex-US Dividend Leaders ETF is ook een luisteraarsvraag binnengekomen en die wordt uiteraard uitvoerig beantwoord door Martijn. Geniet van de podcast! De gepresenteerde informatie door VanEck Asset Management B.V. en de aan haar verbonden en gelieerde bedrijven (samen "VanEck") is enkel bedoeld voor informatie en advertentie doeleinden aan Nederlandse beleggers die Nederlands belastingplichtig zijn en vormt geen juridisch, fiscaal of beleggingsadvies. VanEck Asset Management B.V. is een UCITS-beheerder. Loop geen onnodig risico. Lees de Essentiële Beleggersinformatie of het Essentiële-informatiedocument. Meer informatie? https://www.vaneck.com/nl/nl/See omnystudio.com/listener for privacy information.
We moeten het echt even hebben over chipmaker SK Hynix. Dat wordt volgens persbureau Reuters agressief benaderd door grote techbedrijven. Die bedrijven willen kosten wat kost geheugenchips in handen krijgen. Er is wereldwijd een tekort aan die chips, nu techondernemingen als een gek investeren in kunstmatige intelligentie. Daarom proberen die techreuzen iets anders te verzinnen, om bij SK Hynix aan geheugenchips te komen. Ze zijn bereid ver te gaan. Zo bieden ze geld (investeringen, geld naar speciale productielijnen) en ze zetten zelfs ASML in. De peperdure machines van ASML om precies te zijn. Ze zouden die machines willen kopen, in ruil voor de zekerheid op geheugenchips. Deze aflevering staan we stil bij die bijzondere manier om aan chips te komen. Staan we óók stil bij het bezoek van Donald Trump aan China. Hij gaat volgende week met Xi Jinping om de tafel. In zijn kielzog reizen er ondernemers bij. Nvidia-topman Jensen Huang voelt zich niet te groot om openlijk te solliciteren voor een plekje in die Amerikaanse delegatie. We hebben het nog een keer over Trump, maar dan over zijn heffingen. Die zijn opnieuw illegaal verklaard. In februari werden de heffingen van de president illegaal verklaar en nu is zijn back-up plan dat ook. Verliest hij hiermee zijn ultieme drukmiddel? Verder hebben we het over de ECB. Dat hint op een renteverhoging. Te gast: Erik Mauritz van Trade Republic. BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille. See omnystudio.com/listener for privacy information.
CEO of Philips, Roy Jakobs reviews strong earnings highlighting margin expansion despite inflation and a solid start to the year. He notes the company reiterated full-year guidance and remains focused on controlling what it can within earnings execution. He also mentions increased use of AI in software coding as cost pressures continue to rise.======== Schwab Network ========Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DEmpowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about
From Snowboarding Trip to Nationwide Sleep Business | Bretton Lane on Building Patient-First Sleep CareHow does a snowboarding trip turn into building a nationwide sleep business?In this episode of SleepTech Talk, we sit down with Bretton Beine Lane, President of BetterNight, to unpack her unconventional journey from the slopes to scaling one of the country's leading sleep care organizations.With more than a decade of experience in sleep medicine leadership and operations, Bretton has helped transform sleep care delivery—focusing on improving patient outcomes at scale through innovation and operational excellence.But her story isn't just about business growth—it's about mindset.
Your bank details are at your fingertips on your phone. Your healthcare records? Still scattered across paper files and incompatible systems. Dr. Tina Manoharan spent 16 years at Siemens Healthcare, then led data and AI innovation at Philips, and she's seen firsthand what happens when you deploy AI in an industry where getting it wrong isn't just expensive, it's life or death. We're replaying one of our most fascinating episodes because Tina's framework for AI implementation matters more now than ever.Join hosts Chuck Moxley and Nick Paladino as we revisit Tina's infectious enthusiasm for healthcare innovation. She got genuinely excited when her German doctor put her prescription on a card instead of printing it on paper. The nurse couldn't figure out why someone leading AI innovation for a global company was thrilled about digital prescriptions. That's how far healthcare still lags behind banking.Tina breaks down where AI adds value: oncologists making treatment decisions with no idea what happened to similar patients. Individual doctors see limited cases, but AI learns from thousands across institutions. She flips the script on implementation. Don't start with data, start with the problem. Her Uber example shows you don't automate calling cabs, you transform the workflow. We explore global challenges: US-trained models fail in Asia because organ sizes differ. She discusses navigating FDA, EU AI Act, and NMPA regulations. She emphasizes co-creation: you need clinicians, nurses, and patients, not just data scientists. And she addresses the fear every professional has, “will AI replace my job?” Even doctors asked. Her answer, leaders being innovative won't be replaced, they'll just perform better. Key Actionable Takeaways:Start with the problem, not the data - Never begin with "what data do we have, let's build AI for that"; instead, understand the customer need, map the value flow and data flow, then determine the right AI solution working backwards from the actual problemIntegrate AI into existing workflows, don't force new ones - AI solutions must fit seamlessly into current clinical workflows rather than requiring separate devices or processes; however, be prepared for AI to fundamentally transform workflows like Uber changed transportation, not just automate existing manual tasksCo-create with all stakeholders across disciplines - Include clinicians making decisions, nurses preparing information, patients receiving care, medical officers, sales leaders bringing multi-hospital insights, and clinical partners; AI development requires perspectives from everyone in the value chain to avoid building solutions that don't address real needsWant more tips and strategies about creating frictionless digital experiences? Subscribe to our newsletter! https://www.thefrictionlessexperience.com/frictionless/ Download the Black Friday/Cyber Monday eBook: http://bluetriangle.com/ebook Dr. Tina Manoharan's LinkedIn: https://www.linkedin.com/in/dr-tina-manoharan/ Nick Paladino's LinkedIn: https://linkedin.com/in/npaladino Chuck Moxley's LinkedIn: https://linkedin.com/in/chuck-moxley Chapters:(00:00) Introduction(03:11) Calling from Germany(04:42) Healthcare AI focus areas(06:43) Provider and patient journeys(08:38) Banking vs healthcare digital gap(09:43) Digital patient records globally(11:26) Digital prescription excitement(12:26) Regulatory compliance challenges(14:17) Global AI model differences(16:40) Device ecosystem complexity(18:35) Rare disease diagnosis assistance(20:40) Tumor board decision support(23:16) Co-creation innovation approach(26:02) Starting with data vs problem(27:20) Future state thinking(28:29) Physician AI resistance evolution(32:00) Human fear of replacement(33:10) Uber workflow transformation(35:05) Automation vs AI distinction(37:00) Workflow integration requirements(40:10) Uber payment friction removal(41:00) How to connect
El episodio 115 llegó cargado de revelaciones, drama y debate sin filtro.ASML es la empresa holandesa que hace posible fabricar chips y por ende toda la AI moderna. Nació dentro de Philips, que la dejó ir sin entender lo que tenía. Hoy vale 20 veces más que su propia casa madre. La peor desinversión corporativa de la historia.También hablamos de la biografía no oficial de Anthropic: por qué Dario Amodei tiene todo para ganarle a Sam Altman, y una revelación que pocos conocen — ni los propios creadores de la AI saben cómo funcionan los neural networks por dentro. Son una caja negra total.El juicio oral entre Musk y Altman por OpenAI sigue avanzando con mails internos explosivos. Le dedicamos un episodio completo cuando haya más novedades.Analizamos Chile y su ecosistema sin filtro: Betterfly decepcionó, Notco enfrenta un mercado en caída libre y Buk es el único caso sólido. El diagnóstico: demasiado cómodos para arriesgar.Cerramos con el burnout de founders — por qué pasa y cómo evitarlo — y un caso real de empleados que robaron información propietaria y montaron una empresa competidora.__Muchas gracias a nuestro sponsor Amir por apoyar este episodio!Conseguir ventas es difícil, y acá lo sabemos muy bien. Ya sea que estés en modo indie intentando lanzar tu primer MVP, o buscando escalar como un unicornio, muy probablemente necesites una maquinaria de adquisición funcionando bien. Ahí es donde entra Amir. Él y su equipo te ayudan a lanzar y traccionar si recién estás en fase de lanzamiento, o a escalar de manera predecible si sos una marca consolidada. El servicio es 360 grados, desde optimizar tu sitio web para que convierta mejor hasta implementar estrategias de crecimiento orgánico y pauta publicitaria que realmente funcionen, con métricas claras a lo largo del proceso. Hay algunos cupos para consultorías sin costo esta semana, enviale un mail con el asunto "PODCAST INDIE" a amir@amirgomez.com y hacé crecer tu negocio.__
John 14:1-14[Jesus said,] “Do not let your hearts be troubled. Believe in God, believe also in me. In my Father's house there are many dwelling places. If it were not so, would I have told you that I go there to prepare a place for you. And if I go to prepare a place for you, I will come again and I will take you to myself, so that where I am, there you will be also. And you know the way to the place where I am going.”Thomas said to him, “Lord, we don't know where you are going. How can we know the way?” Jesus said to him, “I am the way and the truth and the life. No one comes to the Father, except through me. If you know me, you know the Father. And from now on, you do know him and you have seen him.”Philip said, “Lord, show us the Father and we will be satisfied.” Jesus said to him, “Have I been with you all this time, Philip, and still you do not know me? Whoever has seen me has seen the Father. How can you say, ‘Show us the Father?' Do you not believe that the Father is in me and that I am in the Father? These words that I say I do not speak on my own, but the Father who dwells in me does his works. Believe me that I am in the Father and that the Father is in me, but if you do not, believe because of the works themselves. “Very truly I tell you, the one who believes in me will also do the works that I do and, indeed, will do greater works than these, because I am going to the Father. I will do whatever you ask for, in my name, so that the Father might be glorified in the Son, If, in my name you ask for anything, I will do it.” Have you ever felt misunderstood? Like you thought you knew how people perceived and received you, but found out their expectations were surprisingly not what you expected? Or worse, that their expectations aren't anything like what you'd want them to think or believe about you?I saw Bruce Springsteen in Chicago on Wednesday. He hasn't released a new album or anything. He's just doing this three-month mini tour of sold-out arenas, mostly around the Midwest, from Minneapolis to Washington, D.C., instigated, I think, by the song he wrote called “Streets of Minneapolis” after the uprisings there, and the killings of Renee Good and Alex Pretti, by ICE agents, this past winter. The tour is inspired, too, by the weight of everything that feels so heavy in the world and in our country these days.It's called “The Land of Hope and Dreams Tour” and the shows are equal parts political protest, prayers for peace, calls for justice, religious rally, if one is so inclined, and cries for unity in our divided nation that Springsteen loves. There were NGO's and volunteers in the concourse advocating for workers' rights and immigrants' rights. There were petitions to sign and non-profits taking donations. The merch wasn't your typical Springsteen concert fare, either – but more social justice-oriented shirts and posters, banners and flags, and whatnot.The setlist included a few standards like “Born to Run” – because you can't have a Springsteen show without “Born to Run” – but the show was mostly a collection of the Boss' best anthems (and some covers) in protest of misguided government, in support of the poor, blue-collar, and middle-class, and in solidarity for the sake of peace in the world. Even “Dancing in the Dark” hits different after all of that and in the context of “The Land of Hope and Dreams Tour.”Anyway, it was perfection. It was exactly what I signed up for, why I was there, and everything that the 25,000 other fans in the sold-out United Center expected – accept perhaps, for some guy in the row behind me. We'll call him Philip. About 2.5 hours into this nearly 3 hour extravaganza, I heard Philip say to his friend something about how he really likes Springsteen's music, but that he could do without all of this political crap. And he sat down while the rest of us danced and sang and cheered – and lost our voices and our minds, with joy – all around him.If Bruce Springsteen could have seen him, he might have said, “Have I been with you all this time, Philip, and still you do not know me?!”I mean, how do you call yourself a fan … how do you spend that kind of money … how do you walk past all of those vendors … see all of that merch … listen, even passively, to “Born in the USA” once or twice over the course of the past 40 years, and still be surprised – and then disappointed – that Bruce Springsteen got political during his “Land of Hope and Dreams” tour?! All of this is to say, I think Bruce Springsteen and Jesus have more in common than just their concern for immigrants, their desire for justice, and their cries for peace and unity in the world. Jesus knew, too – and knows, still – what it means to be misunderstood by too many of his followers.See, my initial hesitation about today's text is always that bit where Jesus says, “No one comes to the Father except through me.” That always gives me pause, because it can be used – and because it has been used – by too many Christians who like to find reason to exclude people from the love of God's grace. The insinuation is that, unless you know Jesus; unless you've been baptized in the name of the Father, Son, and Holy Spirit; unless you've confessed Christ as your Lord and Savior; you'll never make it into God's eternity on the other side of life as we know it.And I suppose that's one way to read it. And if it's right there in black and white – or, even more, if it's written in RED – depending upon the Bible you're reading, than it must be true. But, to me, that seems short-sighted and self-serving and too simplistic in light of everything we know about Jesus – as the way, and the truth, and the life. As the good shepherd. As the Lamb of God who takes away the sin of the world. As the Prince of Peace. As the king of all creation. As the Messiah, the light of the world, as the one who came not to condemn the world, but in order that the world might be saved through him.So, I can't help but wonder if – and hope that – Jesus is saying something exactly the opposite from the restrictive, limited way so many people try to receive this text. What if Jesus is inviting us to read and to wonder about all of this from a different perspective entirely?What if we're supposed to hear, wonder about, and celebrate the “many dwelling places” that are being prepared for us, instead of focusing so much on the one way we get through the door of the house? And what if Jesus' point is that there's room for more than some of us are inclined to think, or expect, or want, if we were the ones in charge? And what if Jesus had a little snark in his voice – and what if we listened with a little more humility – when he says, “…if I go there to prepare a place for you – yeah, you – I will come again and I will take you to myself, so that where I am, there [even] you will be also.” Because if you follow Jesus around long enough – and pay attention to his words and his actions; to his prayers and his teachings; to his living, his dying, and his rising – none of this should surprise you, Philip, or Francia; Thomas or Theresa.“Have I been with you all this time and still you do not know me?”Jesus promised the Kingdom often to all sorts of people, not because they got baptized first; not because they passed some test; not because they got confirmed at the first service this morning; not because they came to worship every Sunday, in a certain kind of church in any particular country. Jesus promised the Kingdom – and people experienced God's heaven – not because they were Lutheran or Catholic or Christian, even, by our standards, anyway.There was that hemorrhaging woman who experienced the power of heaven in her healed body. There was that sinful woman who anointed Jesus' feet who then, because of her faith and forgiveness on this side of the grave, shared the love of God in return. There was that condemned thief who was promised the kingdom from the cross of his own crucifixion.There was the Prodigal Son who's father welcomed him home even though he didn't deserve it. There was the surprisingly good Samaritan who no one thought would do the right thing. There was the proverbial Lost Sheep who the shepherd goes after to save, even at the risk of the rest of the flock.There was Nicodemus, the Pharisee, who came with questions by night. There was Thomas who doubted him. And there was Peter who denied Jesus in his darkest, most desperate hour.Contrary to the misguided expectations of too many Philips in the world, Jesus has shown us exactly who he is and more about the nature of God, the Father, than we are always ready to believe. I think Jesus is saying today that his love has no limits as he showed over and over and over, and time and time and time again. (“If you know me, you will know my Father also,” he promises. “You do know him and you have seen him,” he reminds his disciples.” “Whoever has seen me has seen the Father,” he assures his followers.) And if God, in Jesus, has no limit to the grace he's willing to offer, how dare we expect, pretend, preach, or practice otherwise?Which is to say, I think we're supposed to see Jesus' words about “no one coming to the Father, except through him” not as a threat … or as a means of exclusion … or as a demand for requisite baptism or Christian conversion of some kind. As you've heard me say before, let's stop scaring people away from Hell and start loving them into Heaven, instead.Because I think what Jesus says today is a promise, not a threat … as in, “no one comes to the Father except through me” because there will be a time when, and a place where, ALL will see the fullness of the grace he came to embody as something so large – a mercy so wide – a love so deep – that, through it … because of it … all people … all people … all people … will be welcome and find a home and know the kind of grace, mercy, justice, and peace that only heaven will allow and that the God of the universe exists to share.And in my land of hope and dreams, more of us will come to expect that, to work for that, to celebrate – and not be surprised by that – so that we and the world will be blessed, better, and changed because of that good news.Amen
Discover the latest advancements in smart home technology, featuring insights into Matter support, room-specific heating solutions, and the future of connected devices — all with expert commentary from industry insiders. This week, Mary-Ann Rau joins, CEO of Merino Energy who has launched the very first heat pump to support Apple Home.Key Topics:The significance of Philips' new TV acting as a Matter endpoint and what that means for smart home control.The rise of room-specific heat pumps, exemplified by Merino Energy's innovative, compact, and affordable heat pump with Apple Home integration.The debate over native Apple Home support versus Matter standards in smart devices, and the importance of ecosystem interoperability.Practical showcases of new smart home tools, such as Home Mapper app for device analysis and firmware insights.The strategic approach of companies like Acara, Reolink, and Merino in supporting open standards and proprietary integrations.Send me your smart home questions and recommendations with the hashtag #SmartHomeInsider. Tweet and follow your host at:@andrew_osu on Twitter@andrewohara941 on ThreadsEmail me hereSponsored by:CleanMyMac: Get Tidy Today! Try 7 days free and use my code SMARTHOME for 20% off at https://clnmy.com/SMARTHOME.Smart Home Insider YouTube ChannelSubscribe to the Smart Home Insider YouTube Channel and watch our episodes every week! Click here to subscribe.Links from the showPhilips Amblight TVCyberModStudio TV revealHomeMapper Testflight beta signupAqara W200 written reviewAqara W200 videoHeat pump weekMerino Energy on launching a heat pumpPreorder Merino Heat Pump MonoThose interested in sponsoring the show can reach out to us at: andrew@appleinsider.com
© 2020-2026 Ivy Podcast Discovery LLC
